Your browser doesn't support javascript.
loading
Depressive Symptoms Associated with Peripheral Artery Disease and Predicting Mortality in Type 2 Diabetes.
Li, Yu-Hsuan; Cheng, Yu-Cheng; Liu, Hsiu-Chen; Wu, Junyi; Lee, I-Te.
Affiliation
  • Li YH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
  • Cheng YC; School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
  • Liu HC; Department of Computer Science & Information Engineering, National Taiwan University, Taipei 10617, Taiwan.
  • Wu J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
  • Lee IT; School of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Biomedicines ; 12(1)2023 Dec 21.
Article in En | MEDLINE | ID: mdl-38275390
ABSTRACT
This retrospective cohort study aimed to assess the mortality risk in patients with type 2 diabetes mellitus (DM) by screening for depressive symptoms and peripheral artery disease (PAD). We enrolled patients aged ≥60 years who had undergone assessments of both the ankle-brachial index (ABI) and the five-item Geriatric Depression Scale (GDS-5). PAD and depression were defined as ABI ≤ 0.90 and GDS-5 ≥ 1, respectively. The primary endpoint was total mortality. In 1673 enrolled patients, the prevalence of PAD was higher in those with depression than in those without depression (8.9% vs. 5.7%, p = 0.021). After a median follow-up of 56.6 months (interquartile range 47.0-62.3 months), a total of 168 (10.0%) deaths occurred. The patients in the depression and PAD subgroup had the highest hazard ratio of mortality, followed by the PAD without depression subgroup and the depression without PAD subgroup (2.209, 95%CI 1.158-4.217; 1.958, 95%CI 1.060-3.618; and 1.576, 95%CI 1.131-2.196; respectively) in comparison to the patients without depression and PAD after adjustment for associated factors. In conclusion, a combination of depression and PAD predicted the highest mortality risk. Screening for depression and PAD is recommended in patients aged ≥60 years with type 2 DM.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Biomedicines Year: 2023 Document type: Article Affiliation country: Taiwán Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Biomedicines Year: 2023 Document type: Article Affiliation country: Taiwán Country of publication: Suiza